The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is expected to reach a value of USD 23.3 billion by 2024.

The industry is rapidly growing due to the constant introduction and adoption of automated as well as advanced techniques for laboratory instruments and analyzers in developed countries.

Rising prevalence of infectious diseases and chronic conditions, which require early diagnosis, prevention, and treatment, is one of the main factors boosting the demand for immunoassay analyzers and compact consumable products in the healthcare sector.

In addition, industry is gaining speed with the launch of innovative products such as compact and portable ichroma II of Boditech Med, Inc., which is an FDA-approved fluorescence scanning instrument.

Moreover, with the U.S. FDA approval of the iStat cardiac Troponin I test cartridge that uses enzyme-linked immunosorbant assay (ELISA) method, commercialization of such immunoassay products is also expected to increase significantly over the next few years.

Using this system, number of different assays can be performed in a very short time.Further Key Findings from the Study Suggest:Rapid adoption of advanced technology and automation of laboratory work flow, laboratory instruments, and analyzers is expected to fuel the market growth with CAGR of around 5% over the forecast period.Consumables segment was the largest revenue generating space with over 70% market share in 2015.

Global healthcare cyber security market size is expected to reach nearly USD 10,848.87million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to the growth of the market include the increasing incidences of cyber attacks for misuse of electronic patient health records (E-PHR), social security records, IP theft, and others.

On previous encounters it was witnessed that cyber attacks were focused on stealing, financial information, billing information, and bank account numbers using stolen devices with un-encrypted data, phishing and spam mails.

Furthermore, these organizations face internal threats due to factors such as the use of cloud services, unsecure networks, employee negligence, bring your own device (BYOD), lack of internal identification and security systems, stolen devices with un-encrypted files.

Healthcare cyber security market is segmented by, type of threat into malware, ddos, advanced persistent threat (apt), spyware, lost and stolen devices, others.

Security information and event management (SIEM), risk and compliance management, DDoS mitigation, antivirus, antimalware, identity and access management, intrusion detection system (IDS)/intrusion prevention system (IPS) and others are the solutions included in the scope of the study.

Market dynamics in this sector are dependent on the type of threat, effectiveness, and frequency of attack, ability to detect and destroy.

Global contraceptives market is expected to reach USD 30.86 million by 2022, according to a new study by Grand View Research Inc.

The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute towards the growth of the contraceptives industry.In 2014, contraceptives device was the largest product segment with revenue estimated at over USD 12.0 billion.

Devices such as condoms and contraceptive sponges, which are relatively inexpensive and easy to use, are expected to spearhead market growth over the forecast period.

Female condoms are also expected to gain penetration rates over the next seven years.

Growing user awareness levels and improving product availability are two key factors expected to drive segment growth.Further key findings from the study suggest:Condoms are identified as the most lucrative sub segment of the contraceptive devices market.

The fact that, condoms are effective in preventing sexually transmitted diseases and unwanted pregnancies is also expected to boost usage rates.Intrauterine devices, especially hormonal IUDs are expected to experience attractive growth over the forecast period.

 The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc.

It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus.

The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD).

These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination.

Hence, PGT acts as an addendum to assisted reproductive technology.A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth.

In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.Further key findings from the report suggest:Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles.

The global portable medical devices market size is expected to reach USD 85.3 billion by 2025.

It is anticipated to expand at a CAGR 8.7% over the forecast period, according to a new report by Grand View Research, Inc.

The market is majorly driven by increasing adoption of portable therapeutics, diagnostics, and monitoring devices in healthcare facilities.

Growing usage of small, lightweight, and handheld devices such as spirometers that help in diagnosing the respiratory diseases is anticipated to provide a significant traction to global market in the forthcoming years.Furthermore, upward trend of preventive healthcare and subsequently rising adoption of smart wearables are among other factors boosting growth of the market for portable medical devices.

Fitness trackers and smart watches exhibit features that offer healthcare benefits.

Wearables compute data from day to day activities of users.

The global cannabis extract market size is expected to reach USD 23.7 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 22.1% CAGR over the forecast period.

Growing preference for cannabis extracts such as oils and tinctures, rising legalization of marijuana in various countries, and increase in the adoption of medical marijuana for treatment of various chronic diseases such as Alzheimer’s, cancer, arthritis, and anxiety are key factors promoting cannabis concentrates market growth.The marijuana industry is booming due to increasing awareness about its medical benefits.

Decriminalization and/or legalization of medical marijuana in some countries has led to a significant decrease in the black market as people are resorting to legally purchasing marijuana for medical use.Cannabis oils and tinctures can be used for manufacturing edibles and topicals other than smoking.

These are generally used for treatment of conditions such as cancer, mental disorders, and nausea as well as for recreational purposes such as vaping.

In terms of legality, laws pertaining to medical marijuana extracts are much more lenient compared to that of dried buds, which involve smoking.

Further key findings from the report suggest:In 2018, oils held the largest revenue share of 65.7% owing to their ease of availability and low priceThe full spectrum segment was valued at USD 3.3 billion in 2018, owing to its entourage effect - a synergistic relationship between cannabinoids and terpenes that exhibits an increase in the healing properties of each cannabinoidMarijuana isolates are anticipated to emerge as the second largest type segment owing to its several advantages that have increased its adoption.

 The global biosensors market size is anticipated to reach USD 33.76 billion by 2026 registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc.

Various applications in the medical field, high demand for miniature diagnostic devices, and rapid technological advancements are the key driving factors for biosensors market growth.

Early and precise disease diagnosis is essential for successful prognosis of diseases and survival of patients.

In recent years, the demand for simple, disposable, user-friendly, and cost-efficient devices with fast response time has increased extensively leading to increase in the sales of these products, thereby driving the market.Continuous technological developments are also expected to boost the market.

For instance, in October 2015, Abbott Laboratories launched FreeStyle Libre Glucose Monitoring System in Europe.

It is intended to be a replacement for blood glucose meters.

The global catheters market is expected to reach USD 46.05 billion by 2020, according to a new report by Grand View Research.

Key factors driving the market growth include growing prevalence of obesity, diabetes and cardiovascular diseases and rising demand for minimally invasive procedures.

Introduction of advanced catheters with improved efficacies and increasing number of minimally invasive procedures in emerging Asian markets such as China and India are expected to support the market growth.Research improvements in clinical trials to inhibit the growth of bio-film development on urinary catheter and introduction of hydrophilic coatings for catheter based delivery systems is anticipated to upsurge the demand of novel catheters for various surgical procedures.

Furthermore, growth in the global geriatric population, which is highly prone to infectious diseases, is also expected to attribute towards the industry growth.Unhealthy lifestyle habits such as excessive smoking, alcohol consumption and medical conditions like diabetes that consequently widens the consumer base by facilitating the need for catheter in surgical procedures, is anticipated to significantly boost the usage rate.Cardiovascular catheters is estimated to account for the largest share in 2013 over 39.0% owing to the introduction of technologically advanced devices and high acceptance of this catheter in cardiac interventional procedures such as angiography and angioplasty.However, specialty segment is expected to witness significant gains with the CAGR over 12.0% during the forecast period due to the presence of advance product portfolio that meet the needs of wide spectrum of urological applications such as Foley catheter.Europe is expected to account for nearly 40% of the global revenue generated in 2020 owing to the presence of favorable government initiatives and a sophisticated healthcare infrastructure.Asia Pacific is expected to witness the highest growth at a CAGR of 14.3% over the forecast period owing to novel products development and improving healthcare infrastructure in the region during the forecast period.Key players of the catheter market include Boston Scentific Corporation, Abbott Laboratories, Johnson & Johnson, C.R Bard, Convatech, Cure Medical, Stryker Corporation, and Covidien.

Constant research activities conducted in R departments and introduction of novel products such as NC Euphora Noncomplaint Balloon Dilation and collaboration with the International Diabetes Federation by Medtronic Inc, account for some of key strategic initiatives implemented by the major players. 

The global blockchain technology in healthcare market size is expected to reach USD 11.5 billion by 2026, according to a new report by Grand View Research, Inc.

Furthermore, technological advancements and untapped opportunities in the healthcare sector are some of the major factor leading to the adoption of the technology.Blockchain technology has grown at a rapid pace in the past few years.

The technology has been utilized by the big corporations for profit maximization and cost cutting.

Many leading healthcare and life science companies including Pfizer Inc.; Amerisource Bergen Corporation; McKesson Corporation; and Premier Inc. have all recently joined blockchain-powered project MediLedger to tackle the inadequacies of supply chain.

Reduction or elimination in frauds and errors, reduction in delays from paperwork, identification of issues rapidly, minimization of courier costs, improvement in inventory management, and increase in consumer and partner trust are some of the purported benefits of blockchain technology facilitating supply chain management.Furthermore, the pharmaceutical industry is only one part of the overall healthcare ecosystem which is vigorously exploring the use cases of the blockchain and many of the ideas already have the proof-of-concept implementations.

The hindrances and challenges that arise in multiple level authentication can also be eliminated through the adoption of blockchain.

The global sinus dilation devices market size is expected to reach USD 3.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.9% during the forecast period.

The market is driven by rising prevalence of chronic sinusitis.

Moreover, increasing adoption of minimally invasive procedures owing to favourable reimbursement scenario is projected to augment the market growth.

For instance, according to the Centers for Disease Control and Prevention in 2017, 26.9 million adults in U.S. were diagnosed with sinusitis, which was around 11.0% of the adult American population then.North America was the dominant regional market for sinus dilation devices in 2017.

The growth of this region was mainly due to the presence of a large number of key companies.

Technological developments pertaining to sinus dilation devices by leading companies is expected to augment the North America and Europe market growth.

The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. Increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive market growth over the forecast period.Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum.

Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis.

Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients.Established players in this market are enhancing their portfolio by upgrading existing devices.

On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.

Further key findings from the report suggest:Capsule endoscopy is the largest application segment owing to factors such as growth in cancer screening awareness programs, increase in incidence of Crohn’s disease and bowel cancer, and increase in demand for minimally invasive proceduresNorth America is the dominant region with the largest revenue share.

Wide availability of products, favorable reimbursement policies, increase in government investments in healthcare, and an overall rise in healthcare expenditure support market growthAsia Pacific is expected to witness the fastest growth over the forecast period.

The global osseointegration implants market size is expected to reach USD 9.3 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 7.7% during the forecast period.

Growing number of joint replacement surgeries among geriatric population, rising adoption of minimally invasive surgeries, and advancement in healthcare facilities are anticipated to drive the osseointegration implants market.Key players have been using different strategies such as new product launch, acquisitions, partnerships, joint ventures, and agreements to increase their foothold in this market.

For instance, in April 2018, Integrum SE introduced a revolutionary OPRA implant system.

According to the company, the product will be initially available only in London and would be distributed through London International Patient Services (LIPS), a U.K.-based healthcare treatment organization for international patients seeking treatment.The osseointegration implants market in developed economies, such as U.S., Germany, France, and Australia, is comparatively mature owing to presence of key market players in these countries and high demand for such products.On the other hand, emerging countries in Asia and Latin America currently have a moderate adoption rate of these products, presenting lucrative growth opportunities in future.

Economic growth and rising disposable income in these countries are anticipated to propel market growth.

Manufacturing companies have been investing in these rapidly developing markets, provided pricing and distribution activities are undertaken efficiently.Further key findings from the report suggest:By product, dental implants are projected to exhibit a remarkable CAGR of nearly 9.0% over the forecast period.